Evidence map›Paper›PMID 39896797›Full record

ArticleIDCases2025

Yousra Sbibih, Abderrazak Saddari, Said Ezrari, Elmostapha Benaissa, Yassine Ben Lahlou, Aziza Hami, Mostafa Elouennass, Adil Maleb

Abstract readCase Reports
In one paragraph

Article in IDCases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yousra SbibihLaboratory of Parasitology-Mycology, Mohammed VI University Hospital, Oujda, Morocco.
Abderrazak SaddariFaculty of Medicine and Pharmacy, University Mohamed First, Oujda, Morocco.
Said EzrariFaculty of Medicine and Pharmacy, University Mohamed First, Oujda, Morocco.
Elmostapha BenaissaDepartment of Bacteriology, Mohammed V Teaching Military Hospital, Rabat, Morocco.
Yassine Ben LahlouDepartment of Bacteriology, Mohammed V Teaching Military Hospital, Rabat, Morocco.
Aziza HamiLaboratory of Parasitology-Mycology, Mohammed VI University Hospital, Oujda, Morocco.
Mostafa ElouennassDepartment of Bacteriology, Mohammed V Teaching Military Hospital, Rabat, Morocco.
Adil MalebFaculty of Medicine and Pharmacy, University Mohamed First, Oujda, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pericardial aspergillosis is a rare but potentially fatal opportunistic infection primarily affecting immunocompromised patients. Diagnosis is challenging due to nonspecific clinical manifestations and difficulties in obtaining definitive microbiological confirmation. Risk factors include immunosuppressive therapies, hematologic malignancies, and solid organ transplantation. While pulmonary involvement is most common, cardiac manifestations such as pericarditis are infrequent and often diagnosed post-mortem. We report a case of

Indexed as

Aspergillus fumigatusFungal pericarditisImmunocompromisedPericardial effusionSystemic lupus erythematosus

Identifiers

PMID39896797
PMCPMC11787701

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.